Anti-tumor effects of galangin

doi:10.3760/cma.j.issn.1673-422X.2014.02.003

Abstract

Su Lijuan, Zhang Haitao, Wu Jun. Anti-tumor effects of galangin[J]. Journal of International Oncology, 2014, 41(2): 87-90.

［1］伍俊, 文敏, 张海涛, 等. 高良姜素诱导肺癌A549 细胞凋亡的研究［J］. 肿瘤防治研究, 2011, 38(11): 1228-1231. ［2］ Zhang HT, Luo H, Wu J, et al. Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway［J］. World J Gastroenterol, 2010, 16(27): 3377-3384. ［3］宋宇, 赵琦, 曹阳, 等. 高良姜素对人骨肉瘤MG63细胞增殖的影响及其机制的研究［J］. 中国医学工程, 2012, 20(5)： 56-58. ［4］ Tolomeo M, Grimaudo S, Di Cristina A, et al. Galangin increases the cytotoxic activity of imatinib mesylate in imatinibsensitive and imatinibresistant BcrAbl expressing leukemia cells［J］. Cancer Lett, 2008, 265(2): 289-297. ［5］ Kim DA, Jeon YK, Nam MJ. Galangin induces apoptosis in gastric cancer cells via regulation of ubiquitin carboxyterminal hydrolase isozyme L1 and glutathione Stransferase P［J］. Food Chem Toxicol, 2012, 50(34): 684-688. ［6］ Zhang WJ, Huang QL, Hua ZC. Galangin and TRAIL cooperate to suppress A549 lung cancer proliferation via apoptosis and p38 MAPK activation［J］. Acta Pharmaceutica Sinica B, 2012, 6(2): 569-574. ［7］ Malanchi I, Peinado H, Kassen D, et al. Cutaneous cancer stem cell maintenance is dependent on betacatenin signalling［J］. Nature, 2008, 452(7187): 650-653. ［8］ Gwak J, Oh J, Cho M, et al. Galangin suppresses the proliferation of βcatenin response transcriptionpositive cancer cells by promoting adenomatous polyposis coli/Axin/glycogen synthase kinase3βindependent βcatenin degradation［J］. Mol Pharmacol, 2011, 79(6): 1014-1022. ［9］ Delmulle L, Vanden Berghe T, Keukeleire DD, et al. Treatment of PC3 and DU145 prostate cancer cells by prenylflavonoids from hop (Humulus lupulus L.) induces a caspaseindependent form of cell death［J］. Phytother Res, 2008, 22(2): 197-203. ［10］ Nakamura Y, Yogosawa S, Izutani Y, et al. A combination of indole3carbinol and genistein synergistically induces apoptosis in human colon cancer HT29 cells by inhibiting Akt phosphorylation and progression of autophagy［J］. Mol Cancer, 2009, 8: 100. ［11］ Wu WK, Coffelt SB, Cho CH, et al. The autophagic paradox in cancer therapy［J］.Oncogene, 2012, 31(8): 939-953. ［12］ Eskelinen EL. The dual role of autophagy in cancer［J］. Curr Opin Pharmacol, 2011, 11(4): 294-300. ［13］ Tschan MP, Simon HU. The role of autophagy in anticancer therapy: promises and uncertainties［J］. J Intern Med, 2010, 268(5): 410-418. ［14］ Yousefi S, Simon HU. Autophagy in cancer and chemotherapy［J］. Results Probl Cell Differ, 2009, 49: 183-190. ［15］ Young AR, Narita M, Ferreira M, et al. Autophagy mediates the mitotic senescence transition［J］. Genes Dev, 2009, 23(7): 798-803. ［16］ Psahoulia FH, Moumtzi S, Roberts ML, et al. Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in HaRAStransformed human colon cells［J］. Carcinogenesis, 2007, 28(5): 1021-1031. ［17］ Gossner G, Choi M, Tan L, et al. Genisteininduced apoptosis anautophagocytosis in ovarian cancer cells［J］. Gynecol Oncol, 2007, 105(1): 23-30. ［18］ Wen M, Wu J, Luo H, et al. Galangin induces autophagy through upregulation of p53 in HepG2 cells［J］. Pharmacology, 2012, 89(56): 247-255. ［19］ Tasdemir E, Chiara Maiuri M, Morselli E, et al. A dual role of p53 in the control of autophagy［J］. Autophagy, 2008, 4(6): 810-814. ［20］ Morselli E, Tasdemir E, Maiuri MC, et al. Mutant p53 protein localized in thecytoplasm inhibits autophagy［J］. Cell Cycle, 2008, 7(19): 3056-3061. ［21］ Feng Z. p53 regulation of the IGF1/AKT/mTOR pathways and the endosomal compartment［J］. Cold Spring Harb Perspect Biol, 2010, 2(2): a001057. ［22］ HyerHansen M, Jttel M. AMPactivated protein kinase: a universal regulator of autophagy?［J］. Autophagy, 2007, 3(4): 381-383. ［23］ Crighton D, Wilkinson S, Ryan KM. DRAM links autophagy to p53 and programmed cell death［J］. Autophagy, 2007, 3(1): 72-74. ［24］ Phromnoi K, Yodkeeree S, Anuchapreeda S, et al. Inhibition of MMP3 activity and invasion of the MDAMB231 human invasive breast carcinoma cell line by bioflavonoids［J］. Acta Pharmacol Sin, 2009, 30(8): 1169-1176 . ［25］ Zhang W, Tang B, Huang Q, et al. Galangin inhibits tumor growth and metastasis of B16F10 melanoma［J］. J Cell Biochem, 2013, 114(1): 152-161. ［26］ Lu YH, Lin Tao, Wang ZT, et al. Mechanism and inhibitory effect of galangin and its flavonoid mixture from Alpinia officinarum on mushroom tyrosinase and B16 murine melanoma cells［J］. J Enzyme Inhib Med Chem, 2007, 22(4): 433-438. ［27］ Szliszka E, Czuba ZP, Bronikowska J, et al. Ethanolic extract of propolis augments TRAILinduced apoptotic death in prostate cancer cells［J］. Evid Based Complement Alternat Med, 2011, 2011:535172. ［28］ Chen YY, Chen GW, Luo HB. Molecular insight into the inhibitory mechanism of galangin towards human cytochrome P450 1A2. A modeling study［J］. Lett Drug Des Discov, 2011, 8(3): 216-222.

[1]	Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan. Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity， proliferation， and apoptosis of multiple myeloma cells [J]. Journal of International Oncology, 2024, 51(3): 129-136.
[2]	Shao Jianqiang, Wang Peng, Bai Jie, Li Huixin, Wang Zunyi, Xu Zhihong. The mechanism of extract of ginkgo biloba inducing mitochondrial autophagy in breast cancer cells MCF-7 [J]. Journal of International Oncology, 2024, 51(2): 65-72.
[3]	Zhang Keping, Zhao Yongsheng, Yang Juan, Fu Maoyong. Chlorogenic acid induces mitochondrial dysfunction in lung cancer A549 cells by inhibiting the PI3K-Akt pathway [J]. Journal of International Oncology, 2024, 51(1): 21-28.
[4]	Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong. Effects of Anhydroicaritin on the proliferation， migration and apoptosis of hepatocellular carcinoma cells [J]. Journal of International Oncology, 2023, 50(9): 513-519.
[5]	Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng. Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway [J]. Journal of International Oncology, 2023, 50(8): 449-456.
[6]	Wu Jiali, Zhang Jiahui, Zhang Ping, Xiao Xinyue, Li Rui, Zhang Hongyu. Mechanism of Bcl-2 BH4 selective inhibitor BDA-366 on NK/T cell lymphoma cells [J]. Journal of International Oncology, 2023, 50(7): 413-418.
[7]	Yang Ya, Wang Huili, Liu Yan, Guo Jinfeng, Wang Chunxia, Lyu Min, Shan Changping. Effects of GCSH gene on proliferation and apoptosis of gastric cancer SNU-1 cells [J]. Journal of International Oncology, 2023, 50(5): 257-262.
[8]	Zhu Yi, Chen Jian. Mechanism of hydrogen sulfide in tumorigenesis and development and its donor-mediated anti-tumor effects [J]. Journal of International Oncology, 2023, 50(12): 729-733.
[9]	Lian Haiwei, Yang Shuorui, Liu Renzhong. Mechanism study on regulation of glioblastoma cell proliferation and apoptosis by sciadopitysin combined with CX-4945 through Notch1 pathway [J]. Journal of International Oncology, 2022, 49(6): 321-326.
[10]	Yang Ya, Ning Xiaofei, Li Bingliang, Yao Hui, Shan Changping, Lyu Min. Study on the mechanism of procyanidin mediated anti gastric cancer SNU-1 cell line by inducing the production of reactive oxygen species [J]. Journal of International Oncology, 2022, 49(5): 257-262.
[11]	Jiang Mengting, Wang Jiachun, Zong Jing. Effects of NFAT5 inhibition on proliferation, invasion, migration and apoptosis of lung adenocarcinoma cells [J]. Journal of International Oncology, 2021, 48(6): 321-327.
[12]	Wang Xianwei, Shi Meiyan, Wang Fengqin, Qi Fu, Wang Chaozhe, Zhou Fei. Roles of TSA upregulation miR-4298 targeting inhibition of PADI4 expression in inducing U251 cells apoptosis [J]. Journal of International Oncology, 2021, 48(4): 193-199.
[13]	Ma Xiuzhen, Lu Yan, Zhao Bingbing, Qiu Hongcong, Xu Xun, Wei Min. Effects of total flavonoids from Baeckea frutescens on the migration, invasion and apoptosis of cervical cancer SiHa cells [J]. Journal of International Oncology, 2021, 48(4): 206-211.
[14]	Li Zhefeng, Li Jie, Zhao Xiaoting, Yue Wentao. GLDC regulates proliferation and apoptosis of ovarian cancer cells through PI3K/Akt/mTOR pathway [J]. Journal of International Oncology, 2021, 48(12): 716-722.
[15]	Wei Mengyu, Ma Li. Research advances of Mfn2 in tumor [J]. Journal of International Oncology, 2021, 48(1): 45-47.

Anti-tumor effects of galangin

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments